Cancer preventive effect of pegylatecl interferon α-2b plus ribavirin in a real-life clinical setting in Japan : PERFECT interim analysis

スポンサーリンク

概要

• 論文の詳細を見る
• 2011-10-01

著者

• WATANABE Sumio

  Department of Gastroenterology, Juntendo University School of Medicine

• Kumada Hiromitsu

  Department Of Gastroenterology Toranomon Hospital

• Imawari Michio

  Department Of Gastroenterology Jichi Medical School Omiya Medical Center

• Watanabe Sumio

  Department Of Gastroenterology Juntendo University

• Izumi Namiki

  Department Of Gastroenterology And Hepatology Musashino Red Cross Hospital

• Hashimoto Etsuko

  Department Of Internal Medicine And Gastroenterology Tokyo Women's Medical University

• Moriyasu Fuminori

  Department Of Gastroenterology & Hepatology Tokyo Medical University

• Enomoto Nobuyuki

  First Department Of Internal Medicine Faculty Of Medicine University Of Yamanashi

• Takikawa Hajime

  Department Of Internal Medicine Teikyo University Hospital

• Koike Kazuhiko

  Department Of Environmental And Public Health Sapporo Medical College

• IMAWARI Michio

  Department of Gastroenterology, Showa University School of Medicine

• ENOMOTO Nobuyuki

  First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi

関連論文

• Efficacy and Safety of Combination Therapy of Natural Human Interferon β and Ribavirin in Chronic Hepatitis C Patients with Genotype 2 and High Virus Load
• Efficacy and Safety of Combination Therapy of Natural Human Interferon Beta and Ribavirin in Chronic Hepatitis C Patients with Genotype 1b and High Virus Load
• The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation
• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Efficacy of platinum analogue for advanced hepatocellular carcinoma unresponsive to transcatheter arterial chemoembolization with epirubicin
• The Efficacy of Interferon-beta Monotherapy for Elderly Patients with Type C Hepatitis of Genotype 2
• Potential of laparoscopy in chronic liver disease with hepatitis B and C viruses
• Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus
• Hepatocarcinogenesis Following HCV RNA Eradication by Interferon in Chronic Hepatitis Patients
• The Efficacy of Short-Term Interferon-Beta Therapy for Type C Cirrhotic Patients with Genotype 2a and Low Virus Load
• Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine
• Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma : a pilot study of patients with hepatitis B virus-related cirrhosis
• Efficacy of interferon monotherapy in young adult patients with chronic hepatitis C virus infection
• Cost-effectiveness of radiofrequency ablation and surgical therapy for small hepatocellular carcinoma of 3cm or less in diameter
• Adequate timing of ribavirin reduction in patients with hemolysis during combination therapy of interferon and ribavirin for chronic hepatitis C
• Efficacy of lamivudine treatment in Japanese patients with hepatitis B virus-related cirrhosis
• Efficacy of 6-month interferon therapy in chronic hepatitis B virus infection in Japan
• Infection with hepatitis B virus genotype A in Tokyo, Japan during 1976 through 2001
• Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment
• Factors contributing of ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
• Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitis
• Hepatocellular carcinoma in noncirrhotic young adult patients with chronic hepatitis B viral infection
• Efficacy of interferon retreatment after relapse for chronic hepatitis C patients with biochemical response after first interferon therapy
• Successful control of ruptured hepatocellular carcinoma with radiofrequency ablation
• Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma : differences between young and elderly patients
• Changes in viral loads of lamivudine-resistant mutants during entecavir therapy
• Efficacy and anticarcinogenic activity of interferon for hepatitis C virus-related compensated cirrhosis in patients with genotype 1b low viral load or genotype 2
• Evaluation of long-term biochemical responses to combination therapy of interferon plus ribavirin in those infected with hepatitis C virus genotype 1b and high baseline viral load
• Efficacy of lamivudine therapy in elderly patients with chronic hepatitis B infection
• Type C-chronic hepatitis patients who had autoimmune phenomenon and developed jaundice during interferon therapy
• A randomized, double-blind, controlled trial of natural interferon-β therapy for e-antigen-negative chronic hepatitis B patients with abnormal transaminase levels
• Antitumor activity of anti-C-ERC/mesothelin monoclonal antibody in vivo
• Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis
• High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load
• Low rate of YMDD motif mutations in polymerase gene of hepatitis B virus in chronically infected patients not treated with lamivudine
• Usefulness of serum KL-6 for early diagnosis of idiopathic pulmonary fibrosis in patients with hepatitis C virus
• Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C : a Japanese multi-center study
• -6-THE CLINICAL SIGNIFICANCE OF EXERCISE-INDUCED ST-SEGMENT ELEVATION : Excercise Test : FREE COMMUNICATIONS(I) : PROCEEDINGS OF THE 53th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY
• Nucleotide sequences of hepatitis GB virus C. Identification of highly conserved domains in the 5' noncoding region and detection by polymerase chain reaction
• Repeated administration of recombinant human serum albumin caused no serious allergic reactions in patients with liver cirrhosis : a multicenter clinical study
• Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
• Involvement of GBV-C/HGV in liver diseases in Japan
• Clinical features of hepatitis B virus genotype A in Japanese patients
• Efficacy of prolonged interferon therapy for patients with chronic hepatitis C with HCV-genotype 1b and high virus load
• Decreased renal expressions of heat shock protein-72 and -25 are associated with renal dysfunction in biliary cirrhotic rats
• Epimorphin expression and stellate cell status in mouse liver injury
• Genipin prevents fulminant hepatic failure resulting in reduction of lethality through the suppression of TNF-α production
• Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats
• Randomized contolled clinical trial of lymphoblastoid interferon-α for chronic hepatitis C
• Incidence of the appearance of the red color sign on esophageal varices and its predictive factors : long-term observations of 359 patients with cirrhosis
• Twice-daily administration of interferon-beta for chronic hepatitis C is not superior to a once-daily regimen
• Interferon therapy for flare-up of hepatitis B virus infection after emergence of lamivudine-induced YMDD motif mutant
• Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration
• Distinction between chronic hepatitis and liver cirrhosis in patients with hepatitis C virus infection. Practical discriminant function using common laboratory data
• Progressive and sufficient decrease of hepatitis B core antibody can predict the disappearance of hepatitis B virus DNA in Japanese patients with hepatitis B surface antigen clearance
• Increased response rate to interferon therapy after a second course in hepatitis C patients who show relapse after the initial course
• Hepatic vascular side effects of styrene maleic acid neocarzinostatin in the treatment of hepatocellular carcinoma
• Fluctuation patterns of HCV-RNA serum level in patients with chronic hepatitis C
• A Device for Simultaneous Application of Sclerotherapy and Endoscopic Ligation for Management of Esophageal Varices
• Clinical and virological features of chronic hepatitis C carriers with normal alanine aminotransferase levels despite positive serum HCV-RNA after interferon therapy
• Enzyme-linked immunosorbent assay to detect hepatitis C virus serological groups 1 to 6
• Effect of arterial administration of a high-molecular weight antitumor agent, styrene maleic acid neocarzinostatin, in embolization-resistant liver cancer
• Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α
• Relationship of hepatocellular carcinogenesis with precore mutant virus and serum hepatitis B virus DNA concentration A longitudinal analysis of patients with cirrhosis
• Detection of Hantaviral Antibodies among Patients with Hepatitis of Unknown Etiology in Japan
• Tasurine preserves gap junctional intercellular communication in rat hepatocytes under oxidative stress
• Relapsed duodenal ulcer after cure of Helicobacter pylori infection
• Effects of teprenone on gastric epithelial restoration in a rabbit cultured cell model
• Effects of epidermal growth factor and insulin on migration and proliferation of primary cultured rabbit gastric epithelial cells
• Multiple early esophageal cancers arising from Barrett's esophagus, and a review of cases of early adenocarcinoma in Barrett's esophagus in Japan
• Reduction of gap junction protein connexin 32 in rat atrophic gastric mucosa as an early event in carcinogenesis
• Efficacy of interferon therapy for aged patients with chronic hepatitis C
• Ecabet sodium prevents the delay of wound repair in intestinal epithelial cells induced by hydrogen peroxide
• Novel Evidence Suggesting Clostridium difficile Is Present in Human Gut Microbiota More Frequently than Previously Suspected
• Hepatocyte-specific Pten-deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma
• Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer - A pilot study
• The Superiority of Laparoscopic Examination in Predicting Hepatocellular Carcinoma after Inteferon Therapy for Chronic Type C Hepatitis
• Hepatitis C virus subtype 3b infection in a hospital Japan: Epidemiological study
• Novel Hepatitis B variants in sibling carriers postitive for antibody to hepatitis B surface antigen
• Usefulness of HCV-RNA counts by the method of HCV-bDNA probe in interferon retreatment for patients with HCV-RNA positive chronic hepatitis C
• A Pilot Study of Thymosin α_1 Therapy for Chronic Hepatitis B Patients
• Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma : a longterm cohort study of 892 patients with viral cirrhosis
• Randomized trial of prolonged interferon retreatment for chronic hepatitis C patients with HCV-genotype 1b and high virus load
• Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection
• Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis : Is autoimmune cholangitis an early stage of primary biliary cirrhosis?
• Efficacy of camostat mesilate against dyspepsia associated with non-alcoholic mild pancreatic disease
• A case of pseudoobstruction of the intestine associated with scleroderma dramatically responding to antibiotics
• Sucralfate prevents the delay of wound repair in intestinal epithelial cells by hydrogen peroxide through NF-κB pathway
• Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagy
• Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A_ adenosine receptor in rats
• Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats
• Selective A_ adenosine agonist ATL-146e attenuates acute lethal liver injury in mice
• Liver diseases and metabolic syndrome
• Analysis of Where and Which Types of Proteinase Participate in Lysosomal Proteinase Processing Using Bafilomycin A1 and Hericobacter pylori Vac A Toxin
• EXTRAESOPHAGEAL MANIFESTATIONS OF GERD IN A RAT CHRONIC ACID REFLUX ESOPHAGITIS MODEL
• Ultrasound-guided percutaneous drainage may decrease the mortality of severe acute pancreatitis
• Prolonged treatment with pegylated interferon α 2b plus ribavirin improves sustained virological response in chronic hepatitis C genotype 1 patients with late response in a clinical real-life setting in Japan
• Gastrointestinal Hemorrhage as the First Manifestation of Metastatic Extragonadal Choriocarcinoma
• Cancer preventive effect of pegylatecl interferon α-2b plus ribavirin in a real-life clinical setting in Japan : PERFECT interim analysis

もっと見る 閉じる

スポンサーリンク